Scott Analytics, Inc. offers a variety of programs and services to the stakeholders of sport, including owners, teams, athletes, governing bodies, laboratories and other related persons and entities.
- Frequent collections of blood and urine (each collected approximately once every 14 days).
- All collections are randomly scheduled from the perspective of the athlete with no advanced notice
- Testing involves the longitudinal analysis of athlete bio-markers in blood and urine in addition to the direct detection of prohibited substances found on the most current version of the WADA list of prohibited substances and methods, as updated from time to time by WADA.
Longitudinal Analysis of bio-markers includes:
- Blood cell testing focusing on Hematocrit, Mean Cell Volume, Recticulocyte cell count, Hb mass, Off score and other standard blood test parameters used in the sport; and
- Blood serum testing for FSH, LH, and hGH; and
- Urinanlysis of an athlete’s endogenous steroids
- Collections of Blood (an average of once each month) and Urine (an average of four collections each year).
- Testing involves the longitudinal analysis of athlete bio-markers in blood and urine in addition to the direct detection of prohibited substances found on the most current version of the WADA list of prohibited substances and methods, as updated from time to time by WADA.
Longitudinal Analysis of bio-markers includes:
- Blood cell testing focusing on Hematocrit, Mean Cell Volume, Recticulocyte cell count, Hb mass, Off score and other standard blood test parameters used in the sport; and
- Limited urinanlysis of an athlete’s endogenous steroids.
Customized Event Day testing that can involve:
- Standard “WADA” style collections and testing of a set number of competitors at specific events; or
- Bio-marker pre-screening of competitors; or
- A custom program combining multiple approaches designed to best fit the needs of the event and its budget.
Custom analysis of supplements or other material for the purpose of establishing the existence or absence of a contaminating prohibited substance.
Review, opinion and general consultation on anti-doping matters. |
 |
|